Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Roundtable Top Picks of the Week
- FED Front & Center Again
- RTI: Sector Strength Charts - Where's the Opportunity Now?
- Surging Financial ETFs Beating the Market
- Utility Industry Stock Outlook - June 2013
- 3 Japanese Stocks to Buy Now
- Your Next Stock Should Be Making New Highs
- Anatomy of Success: Stoneridge (SRI)
- RTI: What Will the Fed Do Wednesday?
- AWS 6/18: Can the Fed Afford to Keep the Suspense?
- PFP 6/18: Wednesday Fed Watch
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/18/2013
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The leading industrial gas supplier, Praxair Inc's (PX - Analyst Report) subsidiary, Praxair Distribution Inc. recently announced the acquisition of American Gas Group (AGG). Financial terms of the transaction were not disclosed.
The acquired company, having annual sales of $28 million, is one of the leading specialty gases suppliers in the world. The company employing over 56 people, comprises Specialty Gases of America, Inc., American Specialty Gases Inc., Semiconductor Resources, Inc. and Specialty Gases of America, LLC.
American Gas Group packages an array of specialty gases including EPA Protocols, hydrocarbons, VOC mixtures, reactive mixtures, high-purity chemicals and research-grade gases, in addition to industrial and medical gas products. The acquisition thus adds value to Praxair’s Midwest specialty gas production capabilities.
It is evident from the present scenario that the growth prospects of industrial gas producers are very bright going forward, with demand for gases ever on the rise due to their wide application areas. Praxair aims to achieve annual organic sales growth in the range of 8%-12%, with emerging markets, including South America, Asia, and Mexico, accounting for an estimated target of 45% of total sales by 2015.
In the third quarter 2011, Praxair reported adjusted earnings per share (EPS) of $1.40. The results surpassed the Zacks Consensus Estimate by a penny and rose 16% year over year. Total revenue in the quarter was $2,896 million, up 14.1% year over year and comprehensively beat the Zacks Consensus Estimate of $2,838 million.
The current Zacks Consensus Estimate for the third quarter is $1.36, representing a year-over-year increase of 9.14%. Estimates for the fiscal years 2011 and 2012 are $5.43 and $6.01, reflecting annual growth of 14.64% and 10.66%, respectively.
The company faces stiff competition from its rivals like Air Products and Chemicals Inc. (APD - Analyst Report) and Airgas Inc. (ARG - Snapshot Report). We currently maintain a Neutral recommendation on Praxair.
Get the full Analyst Report on PX - FREE
Get the full Analyst Report on APD - FREE
Get the full Snapshot Report on ARG - FREE